Aspartate Aminotransferase to Platelet Ratio Index (APRI)

APRI is a simple noninvasive index estimating liver fibrosis from the ratio of AST to platelet count.

IU/L
/Liter
IU/L

Indications for Use

Used to non‑invasively stratify liver fibrosis when biopsy or elastography is unavailable, especially in chronic hepatitis C and chronic hepatitis B, to rule out or suggest significant fibrosis or cirrhosis. Provides moderate diagnostic accuracy (AUC ~0.72–0.83 across fibrosis stages) based on large meta‑analyses 1 [Level II evidence]; 2 [Level I evidence]. Helps triage for antiviral treatment and identify low‑risk patients suitable for routine follow‑up.

Insights & Cautions

Offers low‑cost exclusion of advanced fibrosis but has limited accuracy: good NPV at low cutoffs (≈0.5) but poor PPV at higher thresholds (≥1.5) and often underperforms FIB‑4 for ≥F3 disease (systematic review of 286 studies 1 [Level I evidence]). Can be falsely elevated with hepatic inflammation or acute injury. Best used only as an initial triage tool, ideally combined with elastography for confirmation.